Health & Healthcare

Robert A. Iger, Chairman and Chief Executive Officer, The Walt Disney Company, today announced an innovative plan to dedicate more than $100 million in company resources, including cash, products and services, to reinvent the patient and family experience in children’s hospitals across the globe. This initiative will roll out over five years, expanding the Company’s rich legacy of supporting children’s hospitals, which dates back to Walt Disney.

Pfizer announced the release of its 2017 Annual Review, which highlights The Power of Science to showcase how science drives every aspect of Pfizer’s business in its mission to deliver innovative medicines and vaccines to help ensure every individual lives the healthiest life. At Pfizer, we believe there is a science to everything, from research and development, to manufacturing, to patient access and philanthropy. This year’s integrated Annual Review uses the lens of our colleagues to illustrate how The Power of Science drives our strategies for addressing the needs of patients.

Learning that your child has a disorder is very scary. Read how one family has coped with their sons Neonatal Marfan syndrome diagnoses, and learn how your company and its employees can help today!

Superheroes Unite to Protect the Future of Children Diagnosed with Cancer. How Your Business Can be the Ultimate Sidekick to Help CureSearch Make Treatment Possible and Cures Probable for Children with Cancer.

Every day is different because the landscape of research is unpredictable. While you generally have a direction, every project dictates a custom set of questions that have to be tackled. Because of this, every day involves communicating and strategizing with people to understand where we stand on projects and our options going forward. The world around us is continually changing and this impacts us too.

In a typical day, I spend a lot of time in lab running experiments on the various mass spectrometers I utilize for my projects. When I am not in the lab, I am in the office analyzing data, working on manuscripts or planning my next experiment based on the current results I have. There are also weekly meetings that I attend and I help to organize monthly meetings for the post-doctoral fellows at Amgen.

I manage a team of Amgen Neuroscience Discovery Research scientists dedicated to developing new therapeutics for ALS and Parkinson’s disease. As part of this, I set the scientific strategy for my team, and identify and foster collaborations with academic labs/start-up biotech companies to strengthen our pipeline of innovative therapies and technologies. I also play a role in recruiting the next generation of Amgen scientists.

I am a junior scientist working in the Pharmacokinetics & Drug Metabolism (PKDM) department at Amgen for just over a year now. On a normal day, I try to best allocate my time between performing experiments in the lab, analyzing data that I or others have generated that may inform the pharmacokinetics and pharmacodynamics of a candidate compound and participating in team meetings with other scientists across functions at Amgen to disseminate this knowledge to help move a program forward.

Pfizer released its 2017 Annual Review, which highlights how The Power of Science drives every aspect of Pfizer’s business in its mission to deliver innovative medicines and vaccines that help improve health and well-being at every stage of life.

HPRC commences a project to determine viable strategies for recycling mixed flexible plastic packaging currently discarded as hospital waste.